These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20824430)

  • 21. Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice.
    Ryan ET; Butterton JR; Zhang T; Baker MA; Stanley SL; Calderwood SB
    Infect Immun; 1997 Aug; 65(8):3118-25. PubMed ID: 9234763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intranasal Immunization with Influenza Virus-Like Particles Containing Membrane-Anchored Cholera Toxin B or Ricin Toxin B Enhances Adaptive Immune Responses and Protection against an Antigenically Distinct Virus.
    Ji X; Ren Z; Xu N; Meng L; Yu Z; Feng N; Sang X; Li S; Li Y; Wang T; Zhao Y; Wang H; Zheng X; Jin H; Li N; Yang S; Cao J; Liu W; Gao Y; Xia X
    Viruses; 2016 Apr; 8(4):115. PubMed ID: 27110810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local and systemic antibody responses to dextran-cholera toxin B subunit conjugates.
    Bergquist C; Lagergård T; Lindblad M; Holmgren J
    Infect Immun; 1995 May; 63(5):2021-5. PubMed ID: 7537252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
    Liao J; Gibson JA; Pickering BS; Watnick PI
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticarrier immunity suppresses the antibody response to polysaccharide antigens after intranasal immunization with the polysaccharide-protein conjugate.
    Bergquist C; Lagergård T; Holmgren J
    Infect Immun; 1997 May; 65(5):1579-83. PubMed ID: 9125533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-specific immunity in MUC1.Tg mice induced by immunization with peptide vaccines from the cytoplasmic tail of CD227 (MUC1).
    Kohlgraf KG; Gawron AJ; Higashi M; VanLith ML; Shen X; Caffrey TC; Anderson JM; Hollingsworth MA
    Cancer Immunol Immunother; 2004 Dec; 53(12):1068-84. PubMed ID: 15696607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells.
    Sun JB; Raghavan S; Sjöling A; Lundin S; Holmgren J
    J Immunol; 2006 Dec; 177(11):7634-44. PubMed ID: 17114433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of toxin-specific neutralizing immunity by molecularly uniform rice-based oral cholera toxin B subunit vaccine without plant-associated sugar modification.
    Yuki Y; Mejima M; Kurokawa S; Hiroiwa T; Takahashi Y; Tokuhara D; Nochi T; Katakai Y; Kuroda M; Takeyama N; Kashima K; Abe M; Chen Y; Nakanishi U; Masumura T; Takeuchi Y; Kozuka-Hata H; Shibata H; Oyama M; Tanaka K; Kiyono H
    Plant Biotechnol J; 2013 Sep; 11(7):799-808. PubMed ID: 23601492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR(649-684), a mucosal subunit HIV/AIDS vaccine candidate.
    Matoba N; Geyer BC; Kilbourne J; Alfsen A; Bomsel M; Mor TS
    Vaccine; 2006 Jun; 24(23):5047-55. PubMed ID: 16621185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit.
    Odumosu O; Payne K; Baez I; Jutzy J; Wall N; Langridge W
    Immunobiology; 2011 Apr; 216(4):447-56. PubMed ID: 20956025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA.
    McCluskie MJ; Weeratna RD; Payette PJ; Davis HL
    FEMS Immunol Med Microbiol; 2002 Feb; 32(3):179-85. PubMed ID: 11934561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigen choice determines vaccine-induced generation of immunogenic versus tolerogenic dendritic cells that are marked by differential expression of pancreatic enzymes.
    Farkas AM; Marvel DM; Finn OJ
    J Immunol; 2013 Apr; 190(7):3319-27. PubMed ID: 23420890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody Production and Th1-biased Response Induced by an Epitope Vaccine Composed of Cholera Toxin B Unit and Helicobacter pylori Lpp20 Epitopes.
    Li Y; Chen Z; Ye J; Ning L; Luo J; Zhang L; Jiang Y; Xi Y; Ning Y
    Helicobacter; 2016 Jun; 21(3):234-48. PubMed ID: 26332255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection Against
    Pan X; Ke H; Niu X; Li S; Lv J; Pan L
    Front Immunol; 2018; 9():1003. PubMed ID: 29867978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin.
    Luci C; Hervouet C; Rousseau D; Holmgren J; Czerkinsky C; Anjuère F
    J Immunol; 2006 Mar; 176(5):2749-57. PubMed ID: 16493030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody responses in serum and lung to intranasal immunization with Haemophilus influenzae type b polysaccharide conjugated to cholera toxin B subunit and tetanus toxoid.
    Bergquist C; Lagergård T; Holmgren J
    APMIS; 1998 Aug; 106(8):800-6. PubMed ID: 9744766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigen distribution.
    McCluskie MJ; Weeratna RD; Davis HL
    Mol Med; 2000 Oct; 6(10):867-77. PubMed ID: 11126201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The novel combinations of CTB, CpG, and aluminum hydroxide significantly enhanced the immunogenicity of clumping factor A
    Ma J; Wang B; Yu L; Song B; Yu Y; Wu S; Dong Y; Zhu Z; Cui Y
    Biosci Biotechnol Biochem; 2020 Sep; 84(9):1846-1855. PubMed ID: 32501144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response.
    McKenzie SJ; Halsey JF
    J Immunol; 1984 Oct; 133(4):1818-24. PubMed ID: 6470484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulation of HIV-envelope protein with lipid vesicles expressing ganglioside GM1 associated to cholera toxin B enhances mucosal immune responses.
    Lian T; Bui T; Ho RJ
    Vaccine; 1999 Nov; 18(7-8):604-11. PubMed ID: 10547418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.